Technology Description

UC San Diego researchers have invented a deletion mutant of a Streptomyces spp. bacterium intended to facilitate the design and creation of new compounds with anti-bacterial, anti-fungal, anti-cancer, or other bioactive properties. These strains have had more of their genetic content deleted than the existing art, providing more utility for metabolic engineering activities and synthetic biology. One would insert plasmids, BACs, etc., that contain genes and pathways encoding for the production of a bioactive compound of interest into this strain. Alternatively, one could integrate these genes and/or pathways directly into the chromosome, if desired.

Patent Status

Patent Pending

Other Information

Contact

University of California, San Diego Technology Transfer Office / invent@ucsd.edu / tel: View Phone Number. Please reference Tech ID #21245.

Request Additional Information

PEOPLE WHO VIEWED THIS ALSO VIEWED THESE TECHNOLOGIES BY OTHER INVENTORS

• A Method to Generate Novel Bioactive Molecules
• A New Bacterial Metastructure and Methods of Use
• A Gene Delivery System to Express and Evaluate HCV Proteins in Mice
• Oxytocin for the Treatment of Schizophrenia
• Nano-Wire Based Retinal Implants